JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


The Journal of Nuclear Medicine Vol. 33 No. 7 1312-1315
© 1992 by Society of Nuclear Medicine
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Holman, B. L.
Right arrow Articles by Navia, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Holman, B. L.
Right arrow Articles by Navia, B.

A Comparison of Brain Perfusion SPECT in Cocaine Abuse and AIDS Dementia Complex

B. Leonard Holman, Basem Garada, Keith A. Johnson, Jack Mendelson, Elizabeth Hallgring, Siew Koon Teoh, Jonathan Worth and Bradford Navia

Department of Radiology, Brigham and Women's Hospital, Boston, Massachusetts
Alcohol and Drug Abuse Research Center, McLean Hospital, Belmont, Massachusetts
Departments of Neurology and Psychiatry, Massachusetts General Hospital, Boston, Massachusetts
Departments of Radiology, Neurology and Psychiatry, Harvard Medical School, Boston, Massachusetts

Correspondence: For reprints contact: B. Leonard Holman, MD, Chairman, Department of Radiology, Brigham and Women's Hospital, 75 Francis St., Boston, MA 02115.

ABSTRACT

Intravenous drug use is a major risk factor for HIV-1 infection. Since both AIDS dementia complex (ADC) and cocaine have been associated with abnormal brain perfusion imaging, we compared the scintigraphic patterns of ADC patients and cocaine polydrug users with normal control subjects using 99mTc-HMPAO SPECT. We found a high incidence of cortical defects in both ADC (100%) and cocaine-dependent (90%) subjects. In the cocaine and ADC patients, cortical defects were most frequent in the frontal, temporal and parietal lobes and occurred with similar frequency in the two populations. In both groups, the number of cortical defects per subject was higher than normal subjects (10.0 ± 5.0 for ADC, 10.1 ± 5.2 for cocaine and 0.7 ± 1.5 for normal), background activity was high (a 65% and 60% incidence for ADC and cocaine, respectively), and basal ganglia involvement was frequent (40% and 65% for ADC and cocaine). We conclude that the brain perfusion pattern, while a sensitive indicator of ADC, cannot be distinguished from chronic cocaine polydrug use and caution should therefore be applied before entertaining a specific diagnosis.




This article has been cited by other articles:


Home page
NeurologyHome page
B. M. Ances, A. C. Roc, J. Wang, M. Korczykowski, J. Okawa, J. Stern, J. Kim, R. Wolf, K. Lawler, D. L. Kolson, et al.
Caudate blood flow and volume are reduced in HIV+ neurocognitively impaired patients
Neurology, March 28, 2006; 66(6): 862 - 866.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
J. S. Kim, D. H. Moon, G. E. Kim, Y. P. Cho, J. S. Kim, J. S. Ryu, and H. K. Lee
Acetazolamide Stress Brain-Perfusion SPECT Predicts the Need for Carotid Shunting During Carotid Endarterectomy
J. Nucl. Med., November 1, 2000; 41(11): 1836 - 1841.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
L. Chang, T. Ernst, M. Leonido-Yee, and O. Speck
Perfusion MRI detects rCBF abnormalities in early stages of HIV-cognitive motor complex
Neurology, January 25, 2000; 54(2): 389 - 389.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
S. M. Mirsattari, M. E. R. Berry, J. K. Holden, W. Ni, A. Nath, and C. Power
Paroxysmal dyskinesias in patients with HIV infection
Neurology, January 1, 1999; 52(1): 109 - 109.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 1992 by the Society of Nuclear Medicine.